返回 Agenda
Session 8: Labeling Process, Document Management Systems, and Databases
Session Chair(s)
Gerrit Nijveldt, MS, MSc
Global Labeling Consultant
Opus Regulatory Inc., United States
Up-to-date data management systems are increasingly important to comply with SPL requirements in the US and IDMP in the EU, especially for the labeling function, which must look at the complete set of data needed for global and compliance. Labeling groups also frequently employ content authoring systems to consistently apply the data and updates in regulatory documents. This session will discuss the advantages and limitations of content authoring, its relation to data management, and the downstream use of systems that can integrate content and data as possible tracking tools for countries/affiliates.
Learning Objective : At the conclusion of this session, participants should be able to:- Describe the concepts of content authoring for labeling
- Identify advantages and limitations of content authoring for labeling
- Discuss data needs and the importance of data management for labeling related data
Speaker(s)
End-to-End Labeling – A Vision for the Future
Jun Dong, PhD
ITS R&D, Sanofi, United States
Director, Business Partner for Global Regulatory Affairs and Development
Transforming the Labeling Process: How an R&D Approach to Innovation Can Fuel the Future State
Shimon Yoshida, PhD
Pfizer Inc, United Kingdom
Executive Director, International Labeling Group, Global Regulatory Affairs
Structured Authoring as a Tool for Globalization
Julie P. Retzinger, MBA, RN
Astellas Pharma Inc., United States
Senior Director - Global Labeling and CCDS
Structured Authoring as a Tool for Globalization
Camiel Hoogendoorn, MSc
Iperion / Astellas Pharma, Netherlands
Consultant IDMP